Show simple item record

dc.contributor.authorShabgah, AG
dc.contributor.authorFattahi, E
dc.contributor.authorShahneh, FZ
dc.date.accessioned2018-08-26T05:51:22Z
dc.date.available2018-08-26T05:51:22Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41408
dc.description.abstractHuman Th17 pro-inflammatory cells are currently defined as cells that produce IL-17A and F, tumor necrosis factor (TNF)-?, IL-6, IL-21, IL-22 and IL-23. Recently discovered related molecules are forming a family of cytokines, the IL-17 family, IL-17A, IL-17B, IL-17C, IL-17D, IL-17E and IL-17F. The associated receptors for the IL-17 family identified are IL-17R, IL-17RH1, IL-17RL (receptor like), IL-17RD and IL-17RE. This review introduces the roles of IL-17 and Th17 cells in human autoimmune diseases. Studies have shown that T cells with inflammatory effects on epithelial, endothelial and fibroblast cells express IL-17. Th17 cells are supposed to be involved in various autoimmune diseases, such as rheumatoid arthritis, psoriasis, multiple sclerosis, and inflammatory bowel diseases. Base on the biologic functions and regulation, IL-17 has regulatory roles in host defense and chronic inflammation which result in tissue damage and autoimmunity. So the IL-17 links links innate and adaptive immunity and has both beneficial and pathological effects on the immune system. This paper will focus on the possible roles of IL-17 in autoimmune diseases, a fundamental player in immune regulation.
dc.language.isoEnglish
dc.relation.ispartofPostepy dermatologii i alergologii
dc.titleInterleukin-17 in human inflammatory diseases.
dc.typearticle
dc.citation.volume31
dc.citation.issue4
dc.citation.spage256
dc.citation.epage61
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.5114/pdia.2014.40954


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record